Panacea Innovation Limited 13D and 13G filings for Connect Biopharma Holdings Limited:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-21 09:00 am Purchase | 2025-07-21 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 13,950,000 25.100% | 540,000 (+4.03%) | Filing |
| 2024-07-01 4:16 pm Purchase | 2024-06-27 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 13,410,000 24.300% | 1,410,000 (+11.75%) | Filing |
| 2024-02-27 9:00 pm Purchase | 2024-02-23 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 12,000,000 21.800% | 3,100,000 (+34.83%) | Filing |
| 2024-02-13 4:30 pm Purchase | 2024-02-12 | 13D | CONNECT BIOPHARMA HLDGS LTD CNTB | Panacea Innovation Limited | 8,900,000 16.200% | 8,900,000 (New Position) | Filing |